Position: Head of a Junior Group “Translational Immuno-Onco-Pathology”

Code number: 2024-0141

The German Cancer Research Center is the largest biomedical research institution in Germany. With more than 3,000 employees, we operate an extensive scientific program in the field of cancer research.

Together with university partners at seven renowned partner sites, we have established the German Cancer Consortium (DKTK, www.dktk.org).

At the DKTK partner site in Munich, under the leadership of Prof. Dr. Frederick Klauschen at the Institute of Pathology of Ludwig-Maximilians-University Munich (LMU Munich), we are seeking to appoint a creative and highly collaborative early career scientist to lead a junior group at the intersection of immunology, pathology and oncology with a methodological focus on multimodal spatial imaging and omics as well as computational technologies. The junior group will be embedded in the Institute of Pathology, LMU Munich, and work in close collaboration with the Department of Medicine III (Oncology and Hematology) of LMU hospital and further departments focusing on cancer. The scientific interest of the junior group leader should in general match with the scientific profile of the DKTK partner site Munich (https://dktk.dkfz.de/en/sites/munich) and the LMU Munich.

Competitive applicants are expected to establish innovative analytical and computational pipelines for multimodal spatial imaging and omics and apply them to clinically relevant questions in cancer research with existing patient cohorts and in prospective settings. The DKTK partner site Munich and the DKFZ provide access to first class state-of-the-art core facilities in Munich and Heidelberg. Translational research activities are supported by access to large patient cohorts, high quality tumor tissue banks and excellent clinical research facilities. The junior group leader will be employed via the DKFZ in Heidelberg. The junior group will be physically established at LMU Munich, Institute of Pathology (Campus City Centre).


Requirements:

  • University degree in medicine or M.Sc. in life science or computational sciences
  • PhD and/or MD degree in medicine or life sciences or computational sciences with an application focus in biomedicine; applications of medical scientists as well as clinician scientists are welcome
  • Preferentially postdoctoral experience (up to six years)
  • Publication record that highlights the vision for future experimental and computational immuno-oncological projects
  • Strong motivation to acquire competitive national and international third-party funding
  • Team leadership skills
  • Intrinsic interest in establishing local and DKTK/DKFZ-wide collaborations
  • Highly proficient in spoken and written English, German skills are beneficial

Applications should include a CV, copies of all degrees, a list of publications and a 2-page research synopsis that summarizes current / past research accomplishments and outlines the candidate's research program for the next 5 years.

 

Contract period:

  • The position is limited to 5 year. An extension beyond the 5-year period is not possible.
  • The position does not include a tenure option.
  • The position can in principle be part-time.


We offer:

  • Excellent framework conditions: state-of-the-art equipment and opportunities for international networking at the highest level
  • Compensation according to TV-L incl. occupational pension plan and capital-forming payments
  • 30 days of vacation per year
  • Possibility of mobile and part-time work
  • Family-friendly working environment, e.g. parent-child room and advisory services
  • Sustainable travel to work: subsidized Germany job ticket
  • Unleash your full potential: targeted offers for your personal development to further develop your talents
  • Our Corporate Health Management Program offers a holistic approach to your well-being

 

Contact:

If you have any questions about your application, please contact Christine Koppenhöhl, phone +49 (0)89/4400-54627.

If you have any questions about the content of the position, please contact Prof. Dr. Frederick Klauschen, phone +49 (0)89/2180-73602.

Important notice:

The DKFZ is subject to the regulations of the Infection Protection Act (IfSG). As a consequence, only persons who present proof of immunity against measles may work at the DKFZ.

Application Deadline: 18.06.2024

The DKFZ is committed to increase the proportion of women in all areas and positions in which women are underrepresented. Qualified female applicants are therefore particularly encouraged to apply.

Among candidates of equal aptitude and qualifications, a person with disabilities will be given preference.                    

We ask for your understanding that we cannot return application documents that are sent to us by post (Deutsches Krebsforschungszentrum, Personalabteilung, Im Neuenheimer Feld 280, 69120 Heidelberg).